Sfakianakis G N, Sfakianaki E, Paredes A, Abitbol C, Zilleruelo G, Goldberg R N, Strauss J
Department of Radiology (Nuclear Medicine), University of Miami School of Medicine, Fla.
Biol Neonate. 1988;54(5):246-53. doi: 10.1159/000242859.
Baseline and single-dose captopril scintigraphy with 1 mCi of 99mTc-diethylenetriamine-pentaacetic acid (or 99mTc-glucoheptonate) was performed in 5 neonates with renovascular hypertension. Unilateral renal artery thrombosis and/or renal infarction was associated with severe impairment or lack of function on both studies (3 patients). Renal ischemia due to aortic thrombus manifested itself as lack of function only following captopril (2 patients). This approach predicted renal failure as a side effect of captopril therapy in 2 patients, 1 with unilateral (contralateral kidney infarcted) and the other with bilateral renal ischemia from aortic thrombus. Single-dose captopril scintigraphy may be a useful tool to predict tolerance to captopril therapy.
对5例肾血管性高血压新生儿进行了基线和单剂量卡托普利肾闪烁显像检查,使用1毫居里的99m锝-二乙三胺五乙酸(或99m锝-葡庚糖酸盐)。在两项检查中,单侧肾动脉血栓形成和/或肾梗死均与严重功能损害或功能缺失相关(3例患者)。主动脉血栓导致的肾缺血仅在卡托普利给药后表现为功能缺失(2例患者)。该方法预测出2例患者卡托普利治疗的副作用为肾衰竭,1例为单侧(对侧肾梗死),另1例为主动脉血栓导致的双侧肾缺血。单剂量卡托普利肾闪烁显像可能是预测卡托普利治疗耐受性的有用工具。